-+ 0.00%
-+ 0.00%
-+ 0.00%

According to the enterprise research app, Zhejiang Xingcui Biotechnology Co., Ltd. was recently established. The legal representative is Cheng Nana, with a registered capital of 20 million yuan. The business scope includes: cell technology research and development; bio-based material technology research and development; biochemical product technology research and development; and bio-based material manufacturing. According to enterprise research and equity penetration, the company is jointly owned by Zhejiang Yatai Lizhong Holdings Co., Ltd., a wholly-owned subsidiary of Asia Pacific Pharmaceutical, and Merida Health Investment Partnership.

Zhitongcaijing·08/18/2026 02:41:05
Listen to the news
According to the enterprise research app, Zhejiang Xingcui Biotechnology Co., Ltd. was recently established. The legal representative is Cheng Nana, with a registered capital of 20 million yuan. The business scope includes: cell technology research and development; bio-based material technology research and development; biochemical product technology research and development; and bio-based material manufacturing. According to enterprise research and equity penetration, the company is jointly owned by Zhejiang Yatai Lizhong Holdings Co., Ltd., a wholly-owned subsidiary of Asia Pacific Pharmaceutical, and Merida Health Investment Partnership.